Healthtech Startups
17,200 companies tagged Healthtech, with their investors and founders.
0 investors
Siensmetrica uses artificial intelligence and advanced data science to analyze and score medical research, helping healthcare professionals, policymakers, and clinicians identify trustworthy insights and translate them into better patient care. The platform targets research professionals and clinicians seeking to navigate the growing volume of medical studies efficiently.
0 investors
Siesta Medical develops AIRLIFT, a minimally invasive treatment for obstructive sleep apnea (OSA) that repositions the airway to reduce blockage as an alternative to CPAP masks and more invasive surgery. The company markets its treatment to sleep apnea patients and the physicians who treat them.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
SignGlasses develops smart glasses technology that delivers real-time sign language interpretation services for Deaf and hard-of-hearing individuals. The company operates a service delivery and management platform designed to improve communication access and facilitate connections across diverse communities.
0 investors
SignPath Pharma develops small-molecule therapeutics to prevent cardiotoxicity caused by cancer treatments and other primary therapies. The company focuses on cardio-oncology, designing molecules to protect cardiac function in patients undergoing cancer therapy.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Silo Pharma is a developmental-stage biopharmaceutical company (Nasdaq: SILO) developing novel formulations of traditional and psychedelic therapeutics for underserved conditions such as stress-induced psychiatric disorders, chronic pain, and central nervous system diseases. Its pipeline includes programs for PTSD, fibromyalgia, Alzheimer's, and multiple sclerosis, pursued via the FDA 505(b)(2) pathway in collaboration with academic research partners.
0 investors
0 investors
Silver Creek develops growth factor-based therapeutics to promote cell survival and growth in response to injury. The company focuses on rescuing damaged cells through targeted biologic interventions.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors